Madison Wealth Partners Inc purchased a new stake in shares of Merck KGaA (OTCMKTS:MKGAF – Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 8,024 shares of the company’s stock, valued at approximately $1,031,000.
Several other large investors also recently added to or reduced their stakes in MKGAF. Frazier Financial Advisors LLC purchased a new stake in Merck KGaA during the second quarter valued at about $25,000. Rakuten Securities Inc. purchased a new position in shares of Merck KGaA in the second quarter worth about $27,000. Bard Associates Inc. bought a new stake in shares of Merck KGaA in the second quarter valued at approximately $60,000. Kilter Group LLC bought a new stake in shares of Merck KGaA in the second quarter valued at approximately $62,000. Finally, Addison Advisors LLC purchased a new stake in shares of Merck KGaA during the 2nd quarter valued at approximately $90,000. Hedge funds and other institutional investors own 0.10% of the company’s stock.
Merck KGaA Stock Up 0.7%
Merck KGaA stock opened at $163.21 on Friday. Merck KGaA has a 1-year low of $116.68 and a 1-year high of $175.56. The firm has a 50 day simple moving average of $162.62 and a 200 day simple moving average of $148.46. The company has a current ratio of 1.31, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27. The firm has a market capitalization of $21.09 billion, a price-to-earnings ratio of 24.92 and a beta of 0.96.
Merck KGaA Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Recommended Stories
- Five stocks we like better than Merck KGaA
- 2 Biotech Stocks Shaping Up for Major Breakouts
- 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs
- 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run
- Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
